Leprosy Eradication: Renewed Commitment & Progress Ahead of World Leprosy Day
- Global efforts to eliminate leprosy are ongoing, but significant challenges remain, with 172,717 new cases detected worldwide in 2024, according to the World Health Institution (WHO).Despite progress in...
- Leprosy is a chronic infectious disease caused by the bacterium Mycobacterium leprae, affecting the skin and peripheral nerves.
- The disease has been known for millennia, but is curable with multidrug therapy (MDT).
Leprosy Elimination Efforts Face Challenges Despite Progress
Table of Contents
Global efforts to eliminate leprosy are ongoing, but significant challenges remain, with 172,717 new cases detected worldwide in 2024, according to the World Health Institution (WHO).Despite progress in many regions, the disease continues to cause disabilities and stigma, highlighting the need for continued access to treatment.
What is Leprosy?
Leprosy is a chronic infectious disease caused by the bacterium Mycobacterium leprae, affecting the skin and peripheral nerves. If left untreated, it can lead to progressive and permanent disabilities.
The disease has been known for millennia, but is curable with multidrug therapy (MDT). Early diagnosis and treatment are crucial to prevent disabilities and interrupt transmission.
Example: The WHO states that MDT, provided free of charge by partners like Novartis since 2000, is highly effective in curing leprosy. WHO Leprosy Fact sheet
Global Case Numbers and Progress
While significant progress has been made, leprosy remains a public health concern in several countries.Of the 188 countries, areas, or territories reporting data in 2024, 55 reported zero cases. However, 172,717 new cases were reported to the WHO in the same year.
Detail: the WHO emphasizes that sustained efforts are needed to reach zero cases globally, particularly in endemic areas.This includes active case finding,improved diagnostic tools,and ensuring access to MDT for all affected individuals.
Evidence: The WHO’s 2024 data shows a continued, though slowing, decline in new leprosy cases globally. WHO Press Release: World Leprosy Day 2024
The Role of Multidrug Therapy (MDT)
Multidrug therapy (MDT) is the cornerstone of leprosy treatment. It is a combination of antibiotics that effectively kills the Mycobacterium leprae bacteria.
Detail: MDT is provided free of charge by the WHO and its partners, including pharmaceutical companies like Novartis, to ensure accessibility in endemic countries.The standard MDT regimen typically lasts six months or longer, depending on the severity of the disease.
Example: Novartis has collaborated with the WHO since 2000 to donate MDT and clofazimine, a key component of the treatment, to affected countries. Novartis Leprosy Program
World Leprosy Day
World Leprosy Day is observed annually on the last Sunday of January, raising awareness about the disease and advocating for the rights of people affected by leprosy.
Detail: The day serves as a platform to challenge the stigma and discrimination associated with leprosy and to promote early diagnosis and treatment. It also highlights the importance of continued research and investment in leprosy elimination programs.
Evidence: The WHO uses World Leprosy Day to emphasize the need for access to treatment and to share updates on global elimination efforts. WHO World Leprosy Day Campaign